Ocugen, Inc. - Common Stock (NQ:OCGN)

1.020 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ocugen, Inc. - Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

36 37 Next >

Ocugen Announces OCU410ST Receives Orphan Drug Designation for Treatment of ABCA4-Associated Retinopathies

April 27, 2023

U.S. Food & Drug Administration (FDA) grants orphan drug designation to OCU410ST for the treatment of ABCA4-associated retinopathies including Stargardt, RP19 and CORD3

From Ocugen

Via GlobeNewswire

Ocugen, Inc. to Participate in Fireside Chat at the H.C. Wainwright BioConnect Investor Conference

April 26, 2023

From Ocugen

Via GlobeNewswire

Ocugen to Present at Association for Research in Vision and Ophthalmology 2023 Annual Meeting

April 20, 2023

From Ocugen

Via GlobeNewswire

Analyst Ratings for Ocugen ↗

April 17, 2023

Via Benzinga

Ocugen Highlights Interim Data From Gene Therapy Study For Genetic Vision Loss Disorder ↗

April 14, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

April 25, 2023

Tuesday's session saw 286 companies set new 52-week lows.

Via Benzinga

Why Ocugen Stock Eked Out a Win Today ↗

February 28, 2023

The company is clearly progressing on several fronts with its pipeline programs.

Via The Motley Fool

Stocks That Hit 52-Week Lows On Monday ↗

April 24, 2023

On Monday, 147 stocks made new 52-week lows.

Via Benzinga

GETY Stock Alert: Trillium Capital Wants a Seat on Getty Images’ Board ↗

April 14, 2023

Getty Images (GETY) stock is on the rise Friday as investors take note of Trillium Capital seeking a seat on the company's Board.

Via InvestorPlace

SOFI Stock Pops as Bank Stocks Gain ↗

April 14, 2023

SoFi Technologies (SOFI) stock is on the rise Friday as the company's shares rally alongside other shares in the financial sector.

Via InvestorPlace

Ocugen (OCGN) Q4 2022 Earnings Call Transcript ↗

February 28, 2023

OCGN earnings call for the period ending December 31, 2022.

Via The Motley Fool

More Likely to 5x First: Novavax vs. Ocugen ↗

February 16, 2023

They skyrocketed before. It could happen again.

Via The Motley Fool

1 Reason to Buy Ocugen in 2023 and 2 Reasons to Sell ↗

February 04, 2023

Ocugen has recently broadened its pipeline.

Via The Motley Fool

Why Are Bank Stocks JPM, WFC, PNC On The Move Today? ↗

April 14, 2023

Bank stocks are on the move Friday after several big companies in the sector released positive earnings reports this morning.

Via InvestorPlace

Why Is Ocugen (OCGN) Stock Moving Today? ↗

April 14, 2023

Ocugen (OCGN) stock is on the move Friday after the company revealed preliminary results from an ongoing clinical trial.

Via InvestorPlace

Ocugen Announces Positive Preliminary Safety and Efficacy Results from the Phase 1/2 Trial of OCU400, a Modifier Gene Therapy Product Candidate, for the Treatment of Retinitis Pigmentosa and Leber Congenital Amaurosis

April 14, 2023

From Ocugen

Via GlobeNewswire

Ocugen to Host Virtual Investor & Analyst Event on April 14, 2023

April 11, 2023

Company to share preliminary safety and efficacy data from ongoing Phase 1/2 trial of OCU400 for the treatment of retinitis pigmentosa and Leber congenital amaurosis

From Ocugen

Via GlobeNewswire

Ocugen Chief Scientific Officer to Present at 2023 World Vaccine Congress

March 31, 2023

From Ocugen

Via GlobeNewswire

Ocugen Announces FDA Approval for Enrollment of Pediatric Patients in Ongoing OCU400 Phase 1/2 Clinical Trial for the Treatment of Retinitis Pigmentosa (RP) and Leber Congenital Amaurosis (LCA)

March 27, 2023

From Ocugen

Via GlobeNewswire

Ocugen, Inc. to Participate in Fireside Chat at 35th Annual Roth Conference

March 07, 2023

From Ocugen

Via GlobeNewswire

Ocugen Appoints Quan A. Vu to Chief Financial Officer & Chief Business Officer

March 06, 2023

From Ocugen

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2023 ↗

March 01, 2023

Via Benzinga

Why Catalyst Biosciences Shares Are Trading Higher By 105%; Here Are 20 Stocks Moving Premarket ↗

February 28, 2023

Gainers Catalyst Biosciences Inc (NASDAQ: CBIO) rose 105% to $0.49 in pre-market trading. South Korea's GC Biopharma said it has signed an asset purchase agreement with Catalyst Biosciences to acquire...

Via Benzinga

Ocugen Provides Business Update with Fourth Quarter and Full Year 2022 Financial Results

February 28, 2023

From Ocugen

Via GlobeNewswire

Earnings Scheduled For February 28, 2023 ↗

February 28, 2023

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report earnings for its fourth quarter.

Via Benzinga

Ocugen, Inc. Announces Submission of Investigational New Drug Application with U.S. FDA to Initiate a Phase 1 Clinical Trial Evaluating OCU200 for the Treatment of Diabetic Macular Edema

February 27, 2023

From Ocugen

Via GlobeNewswire

Ocugen to Present at Retinal Vascular Disease Drug Development Summit

February 17, 2023

From Ocugen

Via GlobeNewswire

Ocugen to Host Conference Call on Tuesday, February 28 at 8:30 A.M. ET to Discuss Business Updates and Fourth Quarter and Full Year 2022 Financial Results

February 15, 2023

From Ocugen

Via GlobeNewswire

Stocks That Hit 52-Week Lows On Monday ↗

February 13, 2023

On Monday, 42 companies hit new 52-week lows.

Via Benzinga

7 Heavily Shorted Penny Stocks for Your Short-Squeeze Watch List ↗

February 03, 2023

Here are seven heavily shorted penny stocks that can potentially witness a sharp reversal rally in the foreseeable future.

Via InvestorPlace

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

36 37 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.